These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 18575860

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Liposomal cytarabine: new drug. Lymphomatous meningitis: no better than standard cytarabine.
    Prescrire Int; 2006 Feb; 15(81):11-2. PubMed ID: 16548098
    [Abstract] [Full Text] [Related]

  • 23. Flushing out of cerebrospinal fluid as a therapy for acute cerebellar dysfunction caused by high dose of cytosine arabinoside: a case report.
    Pellier I, Leboucher B, Rachieru P, Ifrah N, Rialland X.
    J Pediatr Hematol Oncol; 2006 Dec; 28(12):837-9. PubMed ID: 17164656
    [Abstract] [Full Text] [Related]

  • 24. Does high-dose cytarabine cause cumulative toxicity in patients undergoing consolidation therapy for acute myeloid leukemia?
    Wiernik A, Sperr WR, Weisdorf D, Valent P, Ustun C.
    Am J Hematol; 2013 Jun; 88(6):533-4. PubMed ID: 23526441
    [No Abstract] [Full Text] [Related]

  • 25. Arsenic trioxide and low-dose cytarabine in older patients with untreated acute myeloid leukemia, excluding acute promyelocytic leukemia.
    Roboz GJ, Ritchie EK, Curcio T, Provenzano J, Carlin R, Samuel M, Wittenberg B, Mazumdar M, Christos PJ, Mathew S, Allen-Bard S, Feldman EJ.
    Cancer; 2008 Nov 01; 113(9):2504-11. PubMed ID: 18825661
    [Abstract] [Full Text] [Related]

  • 26. Pharmacokinetics and safety of intrathecal liposomal cytarabine in children aged <3 years.
    Peyrl A, Sauermann R, Traunmueller F, Azizi AA, Gruber-Olipitz M, Gupper A, Slavc I.
    Clin Pharmacokinet; 2009 Nov 01; 48(4):265-71. PubMed ID: 19492871
    [Abstract] [Full Text] [Related]

  • 27. Intensive induction chemotherapy with regimen containing intermediate dose cytarabine in the treatment of de novo acute myeloid leukemia.
    Liu J, Mi Y, Fu M, Yu W, Wang Y, Lin D, Bian S, Wang J.
    Am J Hematol; 2009 Jul 01; 84(7):422-7. PubMed ID: 19484734
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: the AML99 trial from the Japanese Childhood AML Cooperative Study Group.
    Tsukimoto I, Tawa A, Horibe K, Tabuchi K, Kigasawa H, Tsuchida M, Yabe H, Nakayama H, Kudo K, Kobayashi R, Hamamoto K, Imaizumi M, Morimoto A, Tsuchiya S, Hanada R.
    J Clin Oncol; 2009 Aug 20; 27(24):4007-13. PubMed ID: 19620491
    [Abstract] [Full Text] [Related]

  • 30. Sequential continuous infusion of fludarabine and cytarabine associated with liposomal daunorubicin (DaunoXome) (FLAD) in primary refractory or relapsed adult acute myeloid leukemia patients.
    Camera A, Rinaldi CR, Palmieri S, Cantore N, Mele G, Mettivier V, Miraglia E, Mastrullo L, Grimaldi F, Luciano L, Guerriero A, Rotoli B, Ferrara F.
    Ann Hematol; 2009 Feb 20; 88(2):151-8. PubMed ID: 18709502
    [Abstract] [Full Text] [Related]

  • 31. Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy. The Japan Adult Leukemia Study Group.
    Miyawaki S, Kobayashi T, Tanimoto M, Kuriyama K, Murakami H, Yoshida M, Minami S, Minato K, Tsubaki K, Omoto E, Oh H, Jinnai I, Sakamaki H, Hiraoka A, Kanamaru A, Takahashi I, Saito K, Naoe T, Yamada O, Asou N, Kageyama S, Emi N, Ueda T, Tomonaga M, Ohno R.
    Int J Hematol; 1999 Jul 20; 70(1):56-7. PubMed ID: 10446497
    [No Abstract] [Full Text] [Related]

  • 32. Spurious elevation of the cerebrospinous fluid white cell counts in three patients receiving liposomal cytarabine as part of post-remission therapy.
    Swords R, O'Rafferty C, Giles F, Browne P.
    Leukemia; 2008 Dec 20; 22(12):2277-8. PubMed ID: 18528421
    [No Abstract] [Full Text] [Related]

  • 33. [Treatment of leukemic infiltrations of the central nervous system. Preliminary communication].
    Swencz-Szczepanik K, Kołakowska-Polubiec K, Królikiewicz H, Kaczyńska D, Maj S, Pawelski S.
    Acta Haematol Pol; 1978 Dec 20; 9(4):257-61. PubMed ID: 282763
    [Abstract] [Full Text] [Related]

  • 34. Neurologic complications of intrathecal liposomal cytarabine administered prophylactically to patients with non-Hodgkin lymphoma.
    Gállego Pérez-Larraya J, Palma JA, Carmona-Iragui M, Fernández-Torrón R, Irimia P, Rodríguez-Otero P, Panizo C, Martínez-Vila E.
    J Neurooncol; 2011 Jul 20; 103(3):603-9. PubMed ID: 20953897
    [Abstract] [Full Text] [Related]

  • 35. Pharmacokinetics and toxicity of intrathecal liposomal cytarabine in children and adolescents following age-adapted dosing.
    Peyrl A, Sauermann R, Chocholous M, Azizi AA, Jäger W, Höferl M, Slavc I.
    Clin Pharmacokinet; 2014 Feb 20; 53(2):165-73. PubMed ID: 24129691
    [Abstract] [Full Text] [Related]

  • 36. Cytarabine dose for acute myeloid leukemia.
    Mori J, Tsubokura M, Kami M.
    N Engl J Med; 2011 Jun 02; 364(22):2166-7; author reply 2168-9. PubMed ID: 21631342
    [No Abstract] [Full Text] [Related]

  • 37. Intrathecal liposomal cytarabine (lipoCIT) administration in patients with leukemic or lymphomatous meningitis: efficacy and long-term safety in a single institution.
    Brion A, Legrand F, Larosa F, Schillinger F, Garnache-Ottou F, Helias P, Fontan J, Heczko M, Delaby P, Daguindau E, Vuillier J, Chauchet A, Deconinck E.
    Invest New Drugs; 2012 Aug 02; 30(4):1697-702. PubMed ID: 21229289
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Analysis of the role of intratecal liposomal cytarabine in the prophylaxis and treatment of central nervous system lymphomatosis: The Balearic Lymphoma Group experience.
    García-Recio M, Cladera A, Bento L, Dominguez J, Ruiz de Gracia S, Sartori F, Del Campo R, García L, Ballester C, Gines J, Bargay J, Sampol A, Gutiérrez A.
    PLoS One; 2017 Aug 02; 12(6):e0179595. PubMed ID: 28665999
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.